nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2B—Sorafenib—thyroid cancer	0.559	1	CbGbCtD
Amisulpride—Sudden death—Vandetanib—thyroid cancer	0.0189	0.0427	CcSEcCtD
Amisulpride—Torsade de pointes—Vandetanib—thyroid cancer	0.0138	0.0312	CcSEcCtD
Amisulpride—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.013	0.0295	CcSEcCtD
Amisulpride—Embolism venous—Sorafenib—thyroid cancer	0.0129	0.0292	CcSEcCtD
Amisulpride—Endocrine disorder—Vandetanib—thyroid cancer	0.0116	0.0264	CcSEcCtD
Amisulpride—Venous thromboembolism—Epirubicin—thyroid cancer	0.00818	0.0185	CcSEcCtD
Amisulpride—Endocrine disorder—Sorafenib—thyroid cancer	0.00785	0.0178	CcSEcCtD
Amisulpride—Venous thromboembolism—Doxorubicin—thyroid cancer	0.00757	0.0171	CcSEcCtD
Amisulpride—Cardiac arrest—Vandetanib—thyroid cancer	0.00666	0.0151	CcSEcCtD
Amisulpride—Gynaecomastia—Sorafenib—thyroid cancer	0.00582	0.0132	CcSEcCtD
Amisulpride—Neutropenia—Vandetanib—thyroid cancer	0.00566	0.0128	CcSEcCtD
Amisulpride—Weight decreased—Vandetanib—thyroid cancer	0.00548	0.0124	CcSEcCtD
Amisulpride—Hyperglycaemia—Vandetanib—thyroid cancer	0.00546	0.0124	CcSEcCtD
Amisulpride—Depression—Vandetanib—thyroid cancer	0.00538	0.0122	CcSEcCtD
Amisulpride—Bradycardia—Vandetanib—thyroid cancer	0.00493	0.0112	CcSEcCtD
Amisulpride—Embolism venous—Epirubicin—thyroid cancer	0.00477	0.0108	CcSEcCtD
Amisulpride—Cardiac disorder—Vandetanib—thyroid cancer	0.0045	0.0102	CcSEcCtD
Amisulpride—Embolism venous—Doxorubicin—thyroid cancer	0.00441	0.00999	CcSEcCtD
Amisulpride—Angiopathy—Vandetanib—thyroid cancer	0.0044	0.00995	CcSEcCtD
Amisulpride—Mental disorder—Vandetanib—thyroid cancer	0.00424	0.00961	CcSEcCtD
Amisulpride—Malnutrition—Vandetanib—thyroid cancer	0.00422	0.00955	CcSEcCtD
Amisulpride—Muscle spasms—Vandetanib—thyroid cancer	0.00405	0.00918	CcSEcCtD
Amisulpride—Tremor—Vandetanib—thyroid cancer	0.00395	0.00895	CcSEcCtD
Amisulpride—Neutropenia—Sorafenib—thyroid cancer	0.00382	0.00865	CcSEcCtD
Amisulpride—Erectile dysfunction—Sorafenib—thyroid cancer	0.00376	0.00852	CcSEcCtD
Amisulpride—Weight decreased—Sorafenib—thyroid cancer	0.00369	0.00837	CcSEcCtD
Amisulpride—Convulsion—Vandetanib—thyroid cancer	0.00365	0.00827	CcSEcCtD
Amisulpride—Hypertension—Vandetanib—thyroid cancer	0.00364	0.00825	CcSEcCtD
Amisulpride—Anxiety—Vandetanib—thyroid cancer	0.00358	0.0081	CcSEcCtD
Amisulpride—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00357	0.00808	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00357	0.00808	CcSEcCtD
Amisulpride—Hypokinesia—Epirubicin—thyroid cancer	0.00356	0.00807	CcSEcCtD
Amisulpride—Dry mouth—Vandetanib—thyroid cancer	0.00351	0.00795	CcSEcCtD
Amisulpride—Nervous system disorder—Vandetanib—thyroid cancer	0.00338	0.00764	CcSEcCtD
Amisulpride—Skin disorder—Vandetanib—thyroid cancer	0.00334	0.00757	CcSEcCtD
Amisulpride—Hypokinesia—Doxorubicin—thyroid cancer	0.0033	0.00747	CcSEcCtD
Amisulpride—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00325	0.00736	CcSEcCtD
Amisulpride—Insomnia—Vandetanib—thyroid cancer	0.00311	0.00705	CcSEcCtD
Amisulpride—Cardiac disorder—Sorafenib—thyroid cancer	0.00303	0.00687	CcSEcCtD
Amisulpride—Dyspepsia—Vandetanib—thyroid cancer	0.00303	0.00686	CcSEcCtD
Amisulpride—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00301	0.00681	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00297	0.00673	CcSEcCtD
Amisulpride—Fatigue—Vandetanib—thyroid cancer	0.00297	0.00672	CcSEcCtD
Amisulpride—Angiopathy—Sorafenib—thyroid cancer	0.00296	0.00671	CcSEcCtD
Amisulpride—Immune system disorder—Sorafenib—thyroid cancer	0.00295	0.00668	CcSEcCtD
Amisulpride—Constipation—Vandetanib—thyroid cancer	0.00294	0.00667	CcSEcCtD
Amisulpride—Mental disorder—Sorafenib—thyroid cancer	0.00286	0.00648	CcSEcCtD
Amisulpride—Malnutrition—Sorafenib—thyroid cancer	0.00284	0.00644	CcSEcCtD
Amisulpride—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00281	0.00637	CcSEcCtD
Amisulpride—Breast pain—Epirubicin—thyroid cancer	0.00276	0.00624	CcSEcCtD
Amisulpride—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00274	0.0062	CcSEcCtD
Amisulpride—Amenorrhoea—Epirubicin—thyroid cancer	0.00274	0.0062	CcSEcCtD
Amisulpride—Muscle spasms—Sorafenib—thyroid cancer	0.00274	0.00619	CcSEcCtD
Amisulpride—Abdominal pain—Vandetanib—thyroid cancer	0.00272	0.00616	CcSEcCtD
Amisulpride—Angioedema—Sorafenib—thyroid cancer	0.0026	0.00589	CcSEcCtD
Amisulpride—Dyskinesia—Epirubicin—thyroid cancer	0.00256	0.0058	CcSEcCtD
Amisulpride—Breast pain—Doxorubicin—thyroid cancer	0.00255	0.00578	CcSEcCtD
Amisulpride—Leukopenia—Sorafenib—thyroid cancer	0.00255	0.00577	CcSEcCtD
Amisulpride—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00253	0.00574	CcSEcCtD
Amisulpride—Amenorrhoea—Doxorubicin—thyroid cancer	0.00253	0.00574	CcSEcCtD
Amisulpride—Asthenia—Vandetanib—thyroid cancer	0.00247	0.00559	CcSEcCtD
Amisulpride—Hypertension—Sorafenib—thyroid cancer	0.00246	0.00556	CcSEcCtD
Amisulpride—Pruritus—Vandetanib—thyroid cancer	0.00244	0.00551	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00241	0.00545	CcSEcCtD
Amisulpride—Pulmonary embolism—Epirubicin—thyroid cancer	0.00241	0.00545	CcSEcCtD
Amisulpride—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00241	0.00545	CcSEcCtD
Amisulpride—Vaginal inflammation—Epirubicin—thyroid cancer	0.00241	0.00545	CcSEcCtD
Amisulpride—Dry mouth—Sorafenib—thyroid cancer	0.00237	0.00536	CcSEcCtD
Amisulpride—Dyskinesia—Doxorubicin—thyroid cancer	0.00237	0.00536	CcSEcCtD
Amisulpride—Diarrhoea—Vandetanib—thyroid cancer	0.00235	0.00533	CcSEcCtD
Amisulpride—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00234	0.00529	CcSEcCtD
Amisulpride—Nervous system disorder—Sorafenib—thyroid cancer	0.00228	0.00516	CcSEcCtD
Amisulpride—Dizziness—Vandetanib—thyroid cancer	0.00228	0.00515	CcSEcCtD
Amisulpride—Vaginal infection—Epirubicin—thyroid cancer	0.00227	0.00514	CcSEcCtD
Amisulpride—Skin disorder—Sorafenib—thyroid cancer	0.00226	0.00511	CcSEcCtD
Amisulpride—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00223	0.00504	CcSEcCtD
Amisulpride—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00223	0.00504	CcSEcCtD
Amisulpride—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00223	0.00504	CcSEcCtD
Amisulpride—Vomiting—Vandetanib—thyroid cancer	0.00219	0.00496	CcSEcCtD
Amisulpride—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00216	0.00489	CcSEcCtD
Amisulpride—Headache—Vandetanib—thyroid cancer	0.00216	0.00488	CcSEcCtD
Amisulpride—Vaginal infection—Doxorubicin—thyroid cancer	0.0021	0.00476	CcSEcCtD
Amisulpride—Nausea—Vandetanib—thyroid cancer	0.00204	0.00463	CcSEcCtD
Amisulpride—Dyspepsia—Sorafenib—thyroid cancer	0.00204	0.00463	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.002	0.00454	CcSEcCtD
Amisulpride—Fatigue—Sorafenib—thyroid cancer	0.002	0.00453	CcSEcCtD
Amisulpride—Constipation—Sorafenib—thyroid cancer	0.00199	0.0045	CcSEcCtD
Amisulpride—Gastrointestinal pain—Sorafenib—thyroid cancer	0.0019	0.0043	CcSEcCtD
Amisulpride—Urticaria—Sorafenib—thyroid cancer	0.00184	0.00418	CcSEcCtD
Amisulpride—Abdominal pain—Sorafenib—thyroid cancer	0.00184	0.00416	CcSEcCtD
Amisulpride—Hypersensitivity—Sorafenib—thyroid cancer	0.00171	0.00387	CcSEcCtD
Amisulpride—Asthenia—Sorafenib—thyroid cancer	0.00167	0.00377	CcSEcCtD
Amisulpride—Cardiac arrest—Epirubicin—thyroid cancer	0.00166	0.00376	CcSEcCtD
Amisulpride—Pruritus—Sorafenib—thyroid cancer	0.00164	0.00372	CcSEcCtD
Amisulpride—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00159	0.00361	CcSEcCtD
Amisulpride—Diarrhoea—Sorafenib—thyroid cancer	0.00159	0.0036	CcSEcCtD
Amisulpride—Cardiac arrest—Doxorubicin—thyroid cancer	0.00154	0.00348	CcSEcCtD
Amisulpride—Dizziness—Sorafenib—thyroid cancer	0.00154	0.00348	CcSEcCtD
Amisulpride—Vomiting—Sorafenib—thyroid cancer	0.00148	0.00334	CcSEcCtD
Amisulpride—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00148	0.00334	CcSEcCtD
Amisulpride—Headache—Sorafenib—thyroid cancer	0.00145	0.00329	CcSEcCtD
Amisulpride—Neutropenia—Epirubicin—thyroid cancer	0.00141	0.0032	CcSEcCtD
Amisulpride—Nausea—Sorafenib—thyroid cancer	0.00138	0.00312	CcSEcCtD
Amisulpride—Weight increased—Epirubicin—thyroid cancer	0.00137	0.00311	CcSEcCtD
Amisulpride—Weight decreased—Epirubicin—thyroid cancer	0.00137	0.00309	CcSEcCtD
Amisulpride—Hyperglycaemia—Epirubicin—thyroid cancer	0.00136	0.00308	CcSEcCtD
Amisulpride—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00132	0.00299	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—thyroid cancer	0.00131	0.00296	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—thyroid cancer	0.00127	0.00288	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—thyroid cancer	0.00126	0.00286	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00126	0.00285	CcSEcCtD
Amisulpride—Agranulocytosis—Epirubicin—thyroid cancer	0.00126	0.00284	CcSEcCtD
Amisulpride—Bradycardia—Epirubicin—thyroid cancer	0.00123	0.00278	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00122	0.00276	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—thyroid cancer	0.00116	0.00263	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—thyroid cancer	0.00114	0.00258	CcSEcCtD
Amisulpride—Cardiac disorder—Epirubicin—thyroid cancer	0.00112	0.00254	CcSEcCtD
Amisulpride—Angiopathy—Epirubicin—thyroid cancer	0.0011	0.00248	CcSEcCtD
Amisulpride—Immune system disorder—Epirubicin—thyroid cancer	0.00109	0.00247	CcSEcCtD
Amisulpride—Mental disorder—Epirubicin—thyroid cancer	0.00106	0.0024	CcSEcCtD
Amisulpride—Malnutrition—Epirubicin—thyroid cancer	0.00105	0.00238	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—thyroid cancer	0.00104	0.00235	CcSEcCtD
Amisulpride—Tension—Epirubicin—thyroid cancer	0.00103	0.00234	CcSEcCtD
Amisulpride—Nervousness—Epirubicin—thyroid cancer	0.00102	0.00231	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—thyroid cancer	0.00101	0.0023	CcSEcCtD
Amisulpride—Muscle spasms—Epirubicin—thyroid cancer	0.00101	0.00229	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—thyroid cancer	0.00101	0.00229	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—thyroid cancer	0.000979	0.00222	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—thyroid cancer	0.000973	0.0022	CcSEcCtD
Amisulpride—Agitation—Epirubicin—thyroid cancer	0.000966	0.00219	CcSEcCtD
Amisulpride—Tension—Doxorubicin—thyroid cancer	0.000955	0.00216	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—thyroid cancer	0.000945	0.00214	CcSEcCtD
Amisulpride—Leukopenia—Epirubicin—thyroid cancer	0.000941	0.00213	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—thyroid cancer	0.000935	0.00212	CcSEcCtD
Amisulpride—Convulsion—Epirubicin—thyroid cancer	0.000911	0.00206	CcSEcCtD
Amisulpride—Hypertension—Epirubicin—thyroid cancer	0.000908	0.00206	CcSEcCtD
Amisulpride—Agitation—Doxorubicin—thyroid cancer	0.000894	0.00202	CcSEcCtD
Amisulpride—Anxiety—Epirubicin—thyroid cancer	0.000892	0.00202	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000889	0.00201	CcSEcCtD
Amisulpride—Dry mouth—Epirubicin—thyroid cancer	0.000875	0.00198	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—thyroid cancer	0.000871	0.00197	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—thyroid cancer	0.000843	0.00191	CcSEcCtD
Amisulpride—Nervous system disorder—Epirubicin—thyroid cancer	0.000841	0.00191	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—thyroid cancer	0.00084	0.0019	CcSEcCtD
Amisulpride—Skin disorder—Epirubicin—thyroid cancer	0.000833	0.00189	CcSEcCtD
Amisulpride—Hyperhidrosis—Epirubicin—thyroid cancer	0.000829	0.00188	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—thyroid cancer	0.000825	0.00187	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000822	0.00186	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—thyroid cancer	0.00081	0.00183	CcSEcCtD
Amisulpride—Hypotension—Epirubicin—thyroid cancer	0.000802	0.00182	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—thyroid cancer	0.000779	0.00176	CcSEcCtD
Amisulpride—Insomnia—Epirubicin—thyroid cancer	0.000776	0.00176	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—thyroid cancer	0.000771	0.00175	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000768	0.00174	CcSEcCtD
Amisulpride—Somnolence—Epirubicin—thyroid cancer	0.000763	0.00173	CcSEcCtD
Amisulpride—Dyspepsia—Epirubicin—thyroid cancer	0.000755	0.00171	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—thyroid cancer	0.000742	0.00168	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000741	0.00168	CcSEcCtD
Amisulpride—Fatigue—Epirubicin—thyroid cancer	0.00074	0.00168	CcSEcCtD
Amisulpride—Constipation—Epirubicin—thyroid cancer	0.000734	0.00166	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—thyroid cancer	0.000718	0.00163	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—thyroid cancer	0.000706	0.0016	CcSEcCtD
Amisulpride—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000702	0.00159	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—thyroid cancer	0.000699	0.00158	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000685	0.00155	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—thyroid cancer	0.000684	0.00155	CcSEcCtD
Amisulpride—Urticaria—Epirubicin—thyroid cancer	0.000682	0.00154	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—thyroid cancer	0.000679	0.00154	CcSEcCtD
Amisulpride—Abdominal pain—Epirubicin—thyroid cancer	0.000678	0.00154	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000649	0.00147	CcSEcCtD
Amisulpride—Hypersensitivity—Epirubicin—thyroid cancer	0.000632	0.00143	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—thyroid cancer	0.000631	0.00143	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—thyroid cancer	0.000628	0.00142	CcSEcCtD
Amisulpride—Asthenia—Epirubicin—thyroid cancer	0.000616	0.00139	CcSEcCtD
Amisulpride—Pruritus—Epirubicin—thyroid cancer	0.000607	0.00137	CcSEcCtD
Amisulpride—Diarrhoea—Epirubicin—thyroid cancer	0.000587	0.00133	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—thyroid cancer	0.000585	0.00132	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—thyroid cancer	0.00057	0.00129	CcSEcCtD
Amisulpride—Dizziness—Epirubicin—thyroid cancer	0.000567	0.00129	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—thyroid cancer	0.000562	0.00127	CcSEcCtD
Amisulpride—Vomiting—Epirubicin—thyroid cancer	0.000546	0.00124	CcSEcCtD
Amisulpride—Diarrhoea—Doxorubicin—thyroid cancer	0.000543	0.00123	CcSEcCtD
Amisulpride—Headache—Epirubicin—thyroid cancer	0.000538	0.00122	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—thyroid cancer	0.000525	0.00119	CcSEcCtD
Amisulpride—Nausea—Epirubicin—thyroid cancer	0.00051	0.00115	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—thyroid cancer	0.000505	0.00114	CcSEcCtD
Amisulpride—Headache—Doxorubicin—thyroid cancer	0.000497	0.00113	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—thyroid cancer	0.000472	0.00107	CcSEcCtD
